Nolvadex 60 tablets (20 mg/tablet)

Buy Nolvadex 60 tablets (20 mg/tablet)

Product Main Description

Nolvadex 60 tablets (20 mg/tablet) is a prescription medicine containing tamoxifen, a selective oestrogen receptor modulator (SERM). It is used in the treatment of breast cancer, for risk reduction in selected women at moderate or high risk, and in some cases for anovulatory infertility under specialist supervision. Tamoxifen works by blocking oestrogen receptors in breast tissue, which helps slow or prevent the growth of hormone-sensitive breast cancer cells. In women with fertility-related use, it may help stimulate ovulation in carefully selected cases.

In the EU, Nolvadex is a prescription-only medicine and must be used under medical supervision. The 20 mg tablet strength is the standard dose in many indications, and the 60-tablet pack is a dispensing format rather than a separate strength. This medicine is not suitable for self-treatment. Safety monitoring is important because tamoxifen may cause hot flushes, nausea, vaginal bleeding or discharge, fluid retention, thromboembolic events, visual changes, and endometrial effects. Patients should seek medical advice promptly if they develop leg swelling, chest pain, shortness of breath, or abnormal bleeding. Pharma Research .eu provides verified European medical information to support safe, neutral, and regulation-aware understanding of Nolvadex information, Nolvadex uses, tamoxifen active ingredient, and Nolvadex EU guidelines.

Extended Medical Information

Nolvadex 60 tablets (20 mg/tablet) is commonly searched by people looking for Nolvadex information, Nolvadex uses, and tamoxifen active ingredient details. The medicine is primarily used in hormone receptor-positive breast cancer, where it can reduce recurrence risk and help with treatment plans over time. In some settings, it is also used for ovarian stimulation in anovulatory infertility, but this should only occur under specialist care. The number of tablets in the pack does not change the clinical meaning of the medicine; it simply reflects the supply quantity.

For EU-compliant content, the emphasis should remain on patient safety, monitoring, and clear indication-specific use. Tamoxifen may increase the risk of blood clots and can cause visual disturbances or endometrial changes, so patients need follow-up and clear counselling on warning signs. It may also interact with other medicines metabolised by CYP pathways, so a full medication review is important. Content for Pharma Research .eu should remain objective, educational, and non-promotional, with a clear separation between approved therapeutic use and any off-label discussion.

Safety Information

• Use only for indications prescribed by a doctor.

• May cause hot flushes, nausea, vaginal bleeding, and fluid retention.

• Seek urgent medical help for chest pain, shortness of breath, or leg swelling.

• Report any unusual vaginal bleeding or visual changes promptly.

• Use caution with other medicines due to interaction risk.

• Not suitable for self-medication.

• Regular monitoring may be required during treatment.

SEO Phrases

• Nolvadex information.

• Nolvadex uses.

• Tamoxifen active ingredient.

• Nolvadex EU guidelines.

• Nolvadex prescription medicine.

Conclusion

Nolvadex 60 tablets (20 mg/tablet) is a tamoxifen prescription medicine used mainly for breast cancer and selected specialist indications, including some fertility-related use. Safe use depends on medical supervision, awareness of clotting and bleeding risks, and regular monitoring during therapy.